Mr Ryan P Brown, MD | |
1511 Park Ave, 3rd Floor, South Plainfield, NJ 07080-5516 | |
(908) 757-4544 | |
(908) 757-2427 |
Full Name | Mr Ryan P Brown |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 24 Years |
Location | 1511 Park Ave, South Plainfield, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396966750 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 000000000 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Dva Summit Dialysis Ctr | Mountainside, NJ | Dialysis facility |
Rcg Kenilworth | Kenilworth, NJ | Dialysis facility |
Overlook Medical Center | Summit, NJ | Hospital |
Morristown Medical Center | Morristown, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
FONAR Corporation announced today two recent sales of its UPRIGHT® Multi-Position™ MRI scanners. Both sales were to private medical practices that choose to remain anonymous for competitive reasons.
In a new article from the National Institutes of Health (NIH), Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and Harold Varmus, M.D., director of the National Cancer Institute (NCI), join Gary Nabel, M.D., Ph.D., director of NIAID's Vaccine Research Center, and Jeffrey Cohen, M.D., chief of NIAID's Laboratory of Infectious Diseases, in summarizing a recent meeting of experts who gathered to map directions toward an EBV vaccine.
Researchers at NYU School of Medicine have made a novel discovery that could have widespread clinical implications, potentially affecting everything from nutrient metabolism to obesity in children.
Atox Bio, a clinical stage biotechnology company engaged in the development of novel immunemodulators for severe infections in critically ill patients, announced today that the U.S. Food and Drug Administration has granted Fast Track designation to AB103, its lead product, currently in development for the treatment of Necrotizing Soft Tissue Infections (NSTI).
› Verified 9 days ago
Entity Name | Medical Diagnostic Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487696886 PECOS PAC ID: 1456347715 Enrollment ID: O20040422000218 |
News Archive
FONAR Corporation announced today two recent sales of its UPRIGHT® Multi-Position™ MRI scanners. Both sales were to private medical practices that choose to remain anonymous for competitive reasons.
In a new article from the National Institutes of Health (NIH), Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and Harold Varmus, M.D., director of the National Cancer Institute (NCI), join Gary Nabel, M.D., Ph.D., director of NIAID's Vaccine Research Center, and Jeffrey Cohen, M.D., chief of NIAID's Laboratory of Infectious Diseases, in summarizing a recent meeting of experts who gathered to map directions toward an EBV vaccine.
Researchers at NYU School of Medicine have made a novel discovery that could have widespread clinical implications, potentially affecting everything from nutrient metabolism to obesity in children.
Atox Bio, a clinical stage biotechnology company engaged in the development of novel immunemodulators for severe infections in critically ill patients, announced today that the U.S. Food and Drug Administration has granted Fast Track designation to AB103, its lead product, currently in development for the treatment of Necrotizing Soft Tissue Infections (NSTI).
› Verified 9 days ago
Entity Name | Practice Associates Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
FONAR Corporation announced today two recent sales of its UPRIGHT® Multi-Position™ MRI scanners. Both sales were to private medical practices that choose to remain anonymous for competitive reasons.
In a new article from the National Institutes of Health (NIH), Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and Harold Varmus, M.D., director of the National Cancer Institute (NCI), join Gary Nabel, M.D., Ph.D., director of NIAID's Vaccine Research Center, and Jeffrey Cohen, M.D., chief of NIAID's Laboratory of Infectious Diseases, in summarizing a recent meeting of experts who gathered to map directions toward an EBV vaccine.
Researchers at NYU School of Medicine have made a novel discovery that could have widespread clinical implications, potentially affecting everything from nutrient metabolism to obesity in children.
Atox Bio, a clinical stage biotechnology company engaged in the development of novel immunemodulators for severe infections in critically ill patients, announced today that the U.S. Food and Drug Administration has granted Fast Track designation to AB103, its lead product, currently in development for the treatment of Necrotizing Soft Tissue Infections (NSTI).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Ryan P Brown, MD 77 Brant Ave, Suite 200, Clark, NJ 07066-1560 Ph: (732) 382-0091 | Mr Ryan P Brown, MD 1511 Park Ave, 3rd Floor, South Plainfield, NJ 07080-5516 Ph: (908) 757-4544 |
News Archive
FONAR Corporation announced today two recent sales of its UPRIGHT® Multi-Position™ MRI scanners. Both sales were to private medical practices that choose to remain anonymous for competitive reasons.
In a new article from the National Institutes of Health (NIH), Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and Harold Varmus, M.D., director of the National Cancer Institute (NCI), join Gary Nabel, M.D., Ph.D., director of NIAID's Vaccine Research Center, and Jeffrey Cohen, M.D., chief of NIAID's Laboratory of Infectious Diseases, in summarizing a recent meeting of experts who gathered to map directions toward an EBV vaccine.
Researchers at NYU School of Medicine have made a novel discovery that could have widespread clinical implications, potentially affecting everything from nutrient metabolism to obesity in children.
Atox Bio, a clinical stage biotechnology company engaged in the development of novel immunemodulators for severe infections in critically ill patients, announced today that the U.S. Food and Drug Administration has granted Fast Track designation to AB103, its lead product, currently in development for the treatment of Necrotizing Soft Tissue Infections (NSTI).
› Verified 9 days ago
Dr. Alok Goyal, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2509 Park Ave, Suite#1a, South Plainfield, NJ 07080 Phone: 908-668-8290 | |
Priyanka Singh, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2509 Park Ave, Suite 1a, South Plainfield, NJ 07080 Phone: 908-668-8290 | |
Dr. Karl A Hebbe, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1907 Park Ave, Suite 202, South Plainfield, NJ 07080 Phone: 908-561-1313 Fax: 908-561-3917 | |
Shabnam Khety, M.D Nephrology Medicare: Medicare Enrolled Practice Location: 906 Oak Tree Ave Ste K, South Plainfield, NJ 07080 Phone: 908-822-2277 | |
Dr. Edwin Blumberg, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1511 Park Ave, 2nd Floor, South Plainfield, NJ 07080 Phone: 908-756-4438 Fax: 908-756-9160 | |
Mabel Amaryllis Mayorga, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 902 Oak Tree Ave Ste 400, South Plainfield, NJ 07080 Phone: 908-756-0040 Fax: 908-756-1793 | |
Gerald Ngo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 902 Oak Tree Ave Ste 400, South Plainfield, NJ 07080 Phone: 908-756-1703 |